secwatch.observer — SEC 8-K summary
======================================

Issuer:     NANOVIRICIDES, INC. (NNVC)
CIK:        0001379006
Form:       8-K
Filed at:   2026-07-30T10:02:18+00:00
Accession:  0001104659-26-088393
Event type: other_material
Sentiment:  neutral
Materiality: 0.70
Item codes: 1.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

NanoViricides raises ~$3.8M in registered direct offering of common stock and warrants
--------------------------------------------------------------------------------

- Gross proceeds of ~$3.8M from sale of 2,516,339 shares (or pre-funded warrants) and warrants to purchase 2,516,339 shares at $1.75.
- Offering closed on July 27, 2026; net proceeds for working capital, R&D, clinical trials, and strategic purposes.
- CEO and principal stockholder TheraCour Pharma entered 30-day lock-up agreements restricting share sales.
- D. Boral Capital acted as exclusive placement agent with 7.0% cash fee and up to $50,000 expense reimbursement.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1379006/000110465926088393/0001104659-26-088393-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1379006/000110465926088393/tm2621493d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-26-088393

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer